ProtoKinetix Inc PKTX
About Quantitative Ratings
Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.
Trading Information
- Previous Close Price
- $0.02
- Day Range
- $0.02–0.02
- 52-Week Range
- $0.01–0.03
- Bid/Ask
- $0.01 / $0.02
- Market Cap
- $5.20 Mil
- Volume/Avg
- 103,800 / 122,231
Key Statistics
- Price/Earnings (Normalized)
- —
- Price/Sales
- —
- Dividend Yield (Trailing)
- —
- Dividend Yield (Forward)
- —
- Total Yield
- —
Company Profile
ProtoKinetix Inc is a research and development stage biotechnology company focused on scientific medical research of AFGPs (Anti-Freeze Glycoproteins). The AFGP is a compound produced by fish, insects, reptiles, bacteria, and plants that enable survival in freezing temperatures. The company also develops AFGP applications which include regenerative medicine issues including harvesting, processing, storage, and transplanting cells, tissues, and organs and treatments for chronic inflammatory conditions and diseases caused by stress factors, including UV radiation, oxidation, and cryopreservation and hydrogen peroxide.
- Sector
- Healthcare
- Industry
- Biotechnology
- Stock Style Box
- —
- Total Number of Employees
- —
- Website
- https://www.protokinetix.com
Valuation
|
Metric
|
PKTX
|
|---|---|
Price/Earnings (Normalized) | — |
Price/Book Value | 11.91 |
Price/Sales | — |
Price/Cash Flow | — |
Price/Earnings
PKTX
Financial Strength
|
Metric
|
PKTX
|
|---|---|
Quick Ratio | 0.46 |
Current Ratio | 0.48 |
Interest Coverage | — |
Quick Ratio
PKTX
Profitability
|
Metric
|
PKTX
|
|---|---|
Return on Assets (Normalized) | −89.98% |
Return on Equity (Normalized) | −96.91% |
Return on Invested Capital (Normalized) | −96.91% |
Return on Assets
PKTX
Biotechnology Industry Comparables
|
Ticker
|
Name
|
Morningstar Rating for Stocks
|
Capital Allocation
|
Economic Moat
|
Market Cap
|
|---|---|---|---|---|---|
NVO
| Novo Nordisk A/S ADR | Fzsplccv | Vmvtl | $554.7 Bil | |
VRTX
| Vertex Pharmaceuticals Inc | Jfcymrj | Hvsdfr | $102.7 Bil | |
REGN
| Regeneron Pharmaceuticals Inc | Bxfbjdmy | Bxhrdqg | $97.8 Bil | |
MRNA
| Moderna Inc | Nvrdhbv | Ybrph | $41.3 Bil | |
ARGX
| argenx SE ADR | Sdcnkdxz | Wbwp | $22.0 Bil | |
BNTX
| BioNTech SE ADR | Xwhckvlnq | Lrqc | $21.0 Bil | |
ALNY
| Alnylam Pharmaceuticals Inc | Cbvhgzd | Rslldf | $18.2 Bil | |
BMRN
| Biomarin Pharmaceutical Inc | Shttfwjyd | Mndknl | $15.4 Bil | |
RPRX
| Royalty Pharma PLC Class A | Cnhqsspfyf | Lfspvf | $12.5 Bil | |
INCY
| Incyte Corp | Hkkpcrkr | Bjwtqsy | $11.6 Bil |